HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of surgery in multi-modality treatment for carcinomatous pleuritis in patients with non-small cell lung cancer.

AbstractOBJECTIVE:
To evaluate the role of surgery in the treatment of the patients with non-small cell lung cancer with pleural dissemination.
METHODS:
The clinical records of 25 patients (mean age 69 years) diagnosed with carcinomatous pleuritis during a thoracotomy by pathological examination and followed by surgery between 1994 and 2012 were reviewed. The treatment modality, including surgery, the clinicopathologic characteristics and 5-year survival were analyzed.
RESULTS:
There were 16 adenocarcinomas, 6 squamous cell carcinomas and 3 large cell carcinomas. Surgery included resection of the main tumor by partial resection in 10 cases, segmentectomy in 2 cases, lobar resection in 12 cases and bilobectomy in 1 case. Intrathoracic irrigation was performed in 20 cases. The pathological N status was N0/N1/N2/Nx: 10/6/7/2. Fifteen patients received adjuvant therapy. The overall 5-year survival rate was 22.2 %. The 5-year survival rates of the N0, N1 and N2 groups were 36.0, 16.7 and 14.3 %, respectively (p = 0.0068). Nine patients lived more than 3 years including 5 in N0, 3 in N1 and 1 in N2.
CONCLUSIONS:
Surgery should not be excluded from the multi-modality treatment of patients with carcinomatous pleuritis because there are some patients who could benefit from surgery especially if they are in N0 status.
AuthorsTetsuhiko Go, Noriyuki Misaki, Natsumi Matsuura, Sung Soo Chang, Shintarou Tarumi, Hiroyasu Yokomise
JournalSurgery today (Surg Today) Vol. 45 Issue 2 Pg. 197-202 (Feb 2015) ISSN: 1436-2813 [Electronic] Japan
PMID25034395 (Publication Type: Journal Article)
Topics
  • Aged
  • Carcinoma, Non-Small-Cell Lung (complications, mortality, pathology, therapy)
  • Combined Modality Therapy
  • Female
  • Humans
  • Lung Neoplasms (complications, mortality, pathology, therapy)
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Pleura (surgery)
  • Pleural Effusion, Malignant (etiology, surgery)
  • Pleurisy (etiology, surgery)
  • Pneumonectomy
  • Prognosis
  • Retrospective Studies
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: